glp-1 next generation GLP-1S Next-Gen GLP-1 after Ozempic: Retatrutide

10.3892/etm.2015.2585 31 Dan DunnJ.AlvarezL

The Saturday Seminar is a weekly feature that aims to put into written form the kind of content that would be conveyed in a live seminar involving regulatory experts

Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial

The researchers concluded that there was small improvement, but due to the limited number of patients in the study, firm conclusions could not be drawn

Researchers utilize peptides to study biological processes, cellular interactions, and various experimental applications